Lord, Abbett & Co’s SomaLogic, Inc. Class A Common Stock SLGC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-255,363
Closed -$1.15M 627
2022
Q2
$1.15M Buy
255,363
+17,379
+7% +$103K ﹤0.01% 550
2022
Q1
$1.91M Buy
+237,984
New +$2.1M 0.01% 587

Other funds holding SLGC

Lord, Abbett & Co's SLGC Position: Q3 2022 in Review

Lord, Abbett & Co sold out of SomaLogic, Inc. Class A Common Stock (SLGC) in Q3 2022, closing a stake of 255,363 shares — an estimated $1.15M sold.

Lord, Abbett & Co first reported a position in SLGC in Q1 2022 and held it in 2 quarters. The position peaked at $1.91M in Q1 2022. 126 funds tracked by Wall St. Rank hold SLGC as of Q3 2022.

  • Lord, Abbett & Co reported no remaining SomaLogic, Inc. Class A Common Stock position as of Q3 2022 after selling out during the quarter.
  • Lord, Abbett & Co sold 255,363 SomaLogic, Inc. Class A Common Stock shares in Q3 2022, an estimated $1.15M.
  • Lord, Abbett & Co first reported a position in SomaLogic, Inc. Class A Common Stock in Q1 2022 and held it in 2 quarters.
  • Lord, Abbett & Co's SomaLogic, Inc. Class A Common Stock position peaked at $1.91M in Q1 2022.
  • 126 funds tracked by Wall St. Rank held SomaLogic, Inc. Class A Common Stock as of Q3 2022.

Based on Lord, Abbett & Co's 13F filing for Q3 2022, filed 14 Nov 2022.